Samsung, Celltrion lead biosimilar market in Europe, US

Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Celltrion revises up earnings goals to overtake Amgen

Celltrion revises up earnings goals to overtake Amgen

Celltrion Inc., South Korea's leading biosimilar maker, on Wednesday expressed its ambition to join the global top 10 biotech and pharmaceutical com...

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

LegoChem Bio, Amgen sign ADC platform deal for up to $1.2 bn

South Korean pharmaceutical firm LegoChem Biosciences Inc. said on Dec. 23 it has transferred the antibody-drug conjugates (ADC) technology platform...

Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris

Samsung Bioepis’ SB12 shows same clinical effects as Alexion’s Soliris

Samsung Bioepis Co., a biopharmaceutical unit of Samsung Group, said its SB12, a proposed biosimilar to Alexion Pharmaceuticals Inc.’s rare bl...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner